Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YUKAWA-1: Evolocumab in Japanese patients with hypercholesterolemia
NCT01652703Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 2012
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of evolocumab in hypercholesterolemia, sponsored by Amgen. Started Jul 2012; status: completed.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01652703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652703.